Choongang Ocean Co., Ltd., located in Seoul, was incorporated in 1995 and registered on the KOSDAQ in 2001. The company has been recognized for its exceptional technical capabilities in the shipbuilding and power generation industries. This year, the company underwent a name change and embarked on various new businesses, including new drug development, medical solution distribution, and open-source solution services, marking the beginning of its second growth phase. The company changed its name to "Medicoks" and aims to become a leader in the field of new drug development, as the name implies. It also seeks to establish the highest level of expertise in the medical solution distribution and open-source solution businesses. To achieve this, the company will explore domestic and international networks and strive to develop expertise in development, manufacturing, and distribution. The company will practice the three management principles of technology management, trust management, and growth management to realize the success of its existing and new businesses. It will focus on maintaining competitive technical capabilities even after 100 years and will not be a short-sighted company that only focuses on immediate gains. The company will make efforts to gain market trust by quickly responding to market changes and demands. It aims to be a company that provides what shareholders and customers truly desire and will continue to pursue growth management. The company will create a growing environment where all members can work with pride and self-esteem. Choongang Ocean Co., Ltd., now known as Medicoks, will do its best to meet the expectations of customers and shareholders. Thank you.
Headquarters
12F,Assimilation Building, 25-5Yeouido-Dong, Yeongdeungpo-Gu
Seoul; Seoul;
Contact Details: Purchase the Medicox Co. Ltd. report to view the information.
Website: http://www.megabion.co.kr
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service